5 news items
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer's Disease Patients
ATHA
12 Jun 24
of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not based on historical fact and include
Glancy Prongay & Murray LLP and Labaton Keller Sucharow LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Athira Pharma, Inc. - (NASDAQ: ATHA)
ATHA
10 Jun 24
' FEESAND PAYMENT OF LITIGATION EXPENSES
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
ATHA
17 May 24
. The proposed settlement calls for Athira to adopt certain corporate governance reforms and pay lead plaintiffs' attorney's fees, litigation expenses
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
ATHA
15 Apr 24
of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not based on historical fact and include statements
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease
ATHA
11 Apr 24
of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking
- Prev
- 1
- Next